Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Pediatricians at Non-Academic Community Hospitals or Clinics in the U.S.(?)

Council Members in this Study Group: 151

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
ROTARIX(R) Rotavirus Vaccine Will Give Pediatricians Another Vaccination Option | 04-09-2008
Analysis of: FDA Approves ROTARIX(R) Rotavirus Vaccine | www.pipelinereview.com
Author: GLG Expert Contributor

Clinical trials have shown very similar efficacy and safety with both GSK's Rotarix and Merck's Rotateq.  With only two doses needed for Rotarix, pediatricians may opt for a simpler schedule.  Financial consideration will likely play the largest role in adopting the new vaccine.

Influenza Vaccine May Get Much Needed Boost | 03-05-2008
Author: GLG Expert Contributor

Intercell's IC31 may provide a much needed improved immune response to influenza vaccine.  Considering the relatively poor response to this year's influenza vaccine, if Intercell can demonstrate continued superior immune response and clinical efficacy, IC31 may find a home in the influenza vaccine...

Acne Care Remains True to Form | 02-29-2008
Author: GLG Expert Contributor

This excellent review of acne treatments shows that we still rely on the basics for acne treatment: benzoyl peroxide, topical antibiotics, and retinoids.

CVS clinics as seen by a pediatrician | 01-23-2008
Author: GLG Expert Contributor

as a primary csre pediatrician, I see this process having a negative impact on my relationship with my patients.  Issues of continuity of care are my major fear.

Sanofi's Gardasil Should Be As Widely Accepted in Europe as in US | 01-16-2008
Author: GLG Expert Contributor

Sanofi's Gardisil, the first-to-market HPV vaccine for adolescent females, has been fairly widely accepted in the US, albeit with some concerns regarding adverse reactions and cost.  It is likely that EU sales will gradually increase as the vaccine is accepted in Europe as well.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Non-Academic Community Hospital or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Department Chair
  • Physician - Division Head
  • Medical Director
  • Nurse - RN
  • Director
  • Nurse Practitioner

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387